BACKGROUND AND PURPOSE: Cerebrospinal fluid (CSF) leaks of the skull base and spine share a common process of CSF volume loss, and yet only the latter has been associated with spontaneous intracranial hypotension (SIH). Despite published claims that only spinal leaks cause SIH, no prior studies have evaluated brain MR imaging in patients with skull base leaks for findings associated with SIH such as dural enhancement. The purpose of our study was to use a validated brain MR imaging scoring system to evaluate skull base CSF leak patients for findings associated with SIH. MATERIALS AND METHODS: We included patients with confirmed skull base CSF leaks and contrast enhanced pre-operative brain MRI. The pre-operative MR images were reviewed for findings associated with SIH using the Bern score. Patient age, presenting symptoms and their duration, and leak site were also recorded. RESULTS: 31 patients with skull base CSF leaks were included. Mean Bern score was 0.9 (range 0-4, SD 1.1), and only 1 patient (3%) had dural enhancement. Mean age was 53 years (range 18-76). Mean symptom duration was 1.3 years, with 22 patients presenting within one year of symptom onset. 23 patients (74.2%) had intraoperative confirmation of leak from the middle cranial fossa, involving the temporal bone, while 7 (22.6%) had leaks from the anterior skull base. One patient, who had dural enhancement, had an infratentorial CSF leak along the petrous segment of the internal carotid artery. CONCLUSIONS: Our study provides further evidence that skull base and spinal CSF leaks represent distinct pathophysiologies and present with different brain MRI findings. ABBREVIATIONS: SIH = Spontaneous Intracranial Hypotension; IIH = Idiopathic Intracranial Hypertension
Background and Purpose: Recent introduction of photon counting detector (PCD) computed tomography (CT) scanners into clinical practice further improve CT angiography (CTA) depiction of orbital arterial vasculature compared to conventional energy integrating detector (EID) CT scanners. PCD-CTA of the orbit can provide a detailed arterial roadmap of the orbit which can de diagnostic on its own or serve as a helpful planning adjunct for both diagnostic and therapeutic catheter-based angiography of the orbit. Methods: For this review, EID and PCD-CT imaging was obtained in 28 volunteers. The volume CT dose index was closely matched. A dual-energy scanning protocol was used on EID-CT. An ultra-high-resolution (UHR) scan mode was used on PCD-CT. Images were reconstructed at 0.6 mm slice thickness using a closely matched medium-sharp standard resolution (SR) kernel. High-resolution (HR) images with the sharpest quantitative kernel were also reconstructed on PCD-CT at the thinnest slice thickness of 0.2 mm. A denoising algorithm was applied to the HR image series. Results: The imaging description of the orbital vascular anatomy presented in this work was derived from these patients’ PCD-CTA images in combination with review of the literature. We found that orbital arterial anatomy is much better depicted with PCD-CTA, and this work can serve primarily as an imaging atlas of the normal orbital vascular anatomy. Conclusion: With recent advances in technology, arterial anatomy of the orbit is much better depicted with PCD-CTA as opposed to EID-CTA. Current orbital PCD-CTA technology approaches the necessary resolution threshold for reliable evaluation of central retinal artery occlusion.
16 February 2024 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Cushing disease is typically caused by a pituitary adenoma that frequently is small and challenging to detect on conventional MRI. High field strength 7T MRI can leverage increased signal-to-noise and contrast-to-noise ratios compared to lower-field strength MRI to help identify small pituitary lesions. We aim to describe our institutional experience with 7T MRI in patients with Cushing disease and perform a review of the literature. MATERIALS AND METHODS: A retrospective analysis of 7T MRI findings in patients with pathology proven cases of Cushing disease from a single institution, followed by a review of the literature on 7T MRI for Cushing disease. RESULTS: Our institutional experience identified Cushing adenomas in 10/13 (76.9%) patients on 7T, however only 5/13 (38.5%) lesions were discrete. Overall, the imaging protocols used were heterogeneous in terms of contrast dose as well as type of post-contrast T1-weighted sequences (Dynamic, 2D vs 3D, and type of 3D sequence). From our institutional data, specific post-gadolinium T1-weighted sequences were helpful in identifying a surgical lesion as follows: Dynamic Contrast Enhanced 2/7 (28.6%), 2D FSE 4/8 (50%), 3D SPACE 5/6 (83.3%), and 3D MPRAGE 8/11 (72.7%). The literature review identified Cushing adenomas in 31/33 (93.9%) patients on 7T. CONCLUSIONS: 7T MRI for pituitary lesion localization in Cushing disease is a new technique with imaging protocols that varied widely. Further comparative research is needed to identify the optimal imaging technique as well as to assess the benefit of 7T over lower-field strength MRI. ABBREVIATIONS: MRI = Magnetic Resonance Imaging, CT = Computed Tomography, 7T = 7 Tesla, DCE = Dynamic Contrast Enhanced
10 February 2025 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Photon counting detector CT myelography is a recently described technique used for detecting spinal CSF leaks, including CSF-venous fistulas. Various image reconstruction techniques, including smoother versus sharper kernels and virtual monoenergetic images, are available with photon counting CT. Moreover, denoising algorithms have shown promise in improving sharp kernel images. No prior studies have compared image quality of these different reconstructions on photon counting CT myelography. Here, we sought to compare several image reconstructions using various parameters important for the detection of CSF-venous fistulas. MATERIALS AND METHODS: We performed a retrospective review of all consecutive decubitus photon counting CT myelograms performed between 2/1/2022 and 8/1/2024 at one institution. We included patients whose studies had the following reconstructions: Br48-40 keV virtual monoenergetic reconstruction, Br56 low energy threshold (T3D), Qr89-T3D denoised with quantum iterative reconstruction, and Qr89-T3D denoised with a convolutional neural network algorithm. We excluded patients who had extradural CSF on preprocedural imaging or a technically unsatisfactory myelogram. All four reconstructions were independently reviewed by two neuroradiologists. Each reviewer rated spatial resolution, noise, presence of artifacts, image quality, and diagnostic confidence (whether positive or negative) on a 1-5 scale. These metrics were compared using the Friedman test. Additionally, noise and contrast were quantitatively assessed by a third reviewer and compared. RESULTS: The Qr89 reconstructions demonstrated higher spatial resolution than their Br56 or Br48-40keV counterparts. Qr89 with convolutional neural network denoising had less noise, better image quality, and improved diagnostic confidence compared to Qr89 with quantum iterative reconstruction denoising. The Br48-40keV reconstruction had the highest contrast-to-noise ratio quantitatively. CONCLUSIONS: In our study, the sharpest quantitative kernel (Qr89-T3D) with convolutional neural network denoising demonstrated the best performance with regards to spatial resolution, noise level, image quality, and diagnostic confidence for detecting or excluding the presence of a CSF-venous fistula. ABBREVIATIONS: CNR = contrast-to-noise ratio; CVF = CSF-venous fistula; EID = energy integrating detector; PCD = photon counting detector; PCD-CTM = photon counting detector CT myelography; ROI = region of interest; SNR = signal-to-noise ratio; SIH = spontaneous intracranial hypotension; T3D = low-energy threshold; UHR = ultra-high resolution.
22 November 2024 in American Journal of Neuroradiology
Erdheim-Chester Disease (ECD) is a rare, multisystem histiocytic disorder characterized by its variable clinical presentations. Central Nervous System (CNS) involvement is observed in approximately half of ECD patients (up to 76% in some series), and often carries a poorer prognosis. While CNS involvement may remain asymptomatic, others may experience a range of neurological symptoms, including cognitive decline, neuropsychiatric disturbances, motor deficits, cranial or peripheral neuropathies, and endocrine abnormalities. Neuroimaging findings in CNS-ECD are diverse, including neurodegeneration manifesting as cerebral or cerebellar volume loss, solitary or multifocal variably enhancing intraparenchymal lesions along the neuroaxis, meningeal infiltration, involvement of the Hypothalamo-pituitary axis, perivascular sheathing or basal ganglia lesions. Other well documented sites of involvement include the craniofacial region, orbits and spine. Awareness of these findings is relevant, not only because of the non-specific nature of these findings, but also given the high proportion of CNS involvement in ECD as well as the higher mortality associated with CNS involvement. This review provides an in-depth overview of the various manifestations of CNS involvement in ECD and their imaging features, along with a brief overview of the differential considerations which include other histiocytic and non-histiocytic processes. ABBREVIATIONS: ECD=Erdheim-Chester Disease; RDD=Rosai-Dorfman Disease; LCH= Langerhans cell histiocytosis;